Tuesday, January 21, 2025
wellness India Expo
Home Tags Drug

Tag: drug

40th DSIR Foundation Day celebration marks 16 tech transfers from CSIR...

There have been a series of indigenous developments namely India’s 1st Indigenously developed Antibiotic- Nafithromycin to treat both atypical and typical drug-resistant bacteria, says Dr Jitendra Singh

India coronary stent market set for 4% CAGR growth during 2024-2033,...

India’s coronary drug eluting stent market accounts for around 32% of the Asia-Pacific market in 2024

Alkem signs licensing deal with Sonnet BioTherapeutics to launch its drug...

Sonnet’s drug candidate “SON-080” has shown encouraging data in phase 1b clinical trial

China’s surge in antibody-drug conjugates positions it as key oncology market,...

ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.

IIT Madras researchers identify enhanced drug delivery method for eye treatments

Researchers demonstrate how mild laser-induced convection can enhance the delivery of drugs injected into the eye to the retina

CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...

Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets

Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization...

Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI

SynaptixBio expands collaboration with Evotec to advance treatments for H-ABC

The extended partnership aims to develop new therapies for severe TUBB4A leukodystrophy, building on research from CHOP

GSK acquires oligonucleotide drug startup Elsie

This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology

Enzene launches discovery services division at BIO 2024

CDMO provides end-to-end drug discovery, development and commercialization services with sites in both the USA and Asia